Human toxicology of BCG applied in cancer immunotherapy
- 1 March 1976
- journal article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 1-1 (1-2) , 69-76
- https://doi.org/10.1007/bf00205297
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The second generation of EORTC-ICIG experimental screening for systemic immunity adjuvants: Its significance for cancer immunotherapy. A comparison of BCG and its hydrosoluble extractPublished by Elsevier ,1975
- MALIGNANT MELANOMA ARISING DE NOVO WITHIN A B.C.G. SCARIFICATION SITEThe Lancet, 1975
- Immunotherapy of melanoma with BCG: Two fatalities following intralesional injectionCancer, 1975
- CHEMOIMMUNOTHERAPY OF ADULT ACUTE LEUKÆMIA PROLONGATION OF REMISSION IN MYELOBLASTIC LEUKÆMIA WITH B.C.G.The Lancet, 1974
- GRANULOMATOUS HEPATITIS: A COMPLICATION OF B.C.G. IMMUNOTHERAPYThe Lancet, 1973
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- Serum‐mediated blocking of cell‐mediated anti‐tumor immunity in a melanoma patient: Association with BCG immunotherapy and clinical deteriorationInternational Journal of Cancer, 1972
- Treatment of Acute Lymphoblastic Leukaemia: PRELIMINARY REPORT BY THE LEUKAEMIA COMMITTEE AND THE WORKING PARTY ON LEUKAEMIA IN CHILDHOODBMJ, 1971
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- Aerogenic BCG Vaccination Against Tuberculosis in Animal and Human SubjectsJournal of Asthma Research, 1968